Andrei Kutlin
Overview
Explore the profile of Andrei Kutlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar S, Smith-Norowitz T, Kohlhoff S, Apfalter P, Roblin P, Kutlin A, et al.
J Immunotoxicol
. 2015 Feb;
13(1):77-83.
PMID: 25640695
Cigarette smoke exposure has been considered a risk factor for infection with Chlamydia pneumoniae. C. pneumoniae infection is associated with respiratory tract infection and chronic respiratory disease, which is a...
2.
Bowser C, Kumar S, Salciccioli L, Kutlin A, Lazar J, Rahim I, et al.
Pediatr Cardiol
. 2007 Dec;
29(3):545-51.
PMID: 18080155
Patients with systemic lupus erythematosus (SLE) have accelerated atherogenesis. A recent study suggested that Chlamydia pneumoniae infection might also be a contributing factor in the development of atherogenesis in patients...
3.
Kohlhoff S, Kutlin A, Riska P, Roblin P, Roman C, Hammerschlag M
Microb Pathog
. 2007 Sep;
44(1):34-42.
PMID: 17888618
Persistent infection with the obligate intracellular pathogen Chlamydophila pneumoniae has been implicated in the pathogenesis of many chronic diseases, but its mechanism remains unclear. Many pathogens have been found to...
4.
Kutlin A, Roblin P, Kumar S, Kohlhoff S, Bodetti T, Timms P, et al.
J Med Microbiol
. 2007 Feb;
56(Pt 3):407-417.
PMID: 17314374
Chlamydophila pneumoniae is an obligate intracellular respiratory pathogen that has been associated with pneumonia and chronic bronchitis, atherosclerosis, asthma and other chronic diseases in humans. However, C. pneumoniae is not...
5.
Kumar S, Kutlin A, Roblin P, Kohlhoff S, Bodetti T, Timms P, et al.
J Clin Microbiol
. 2006 Nov;
45(2):392-4.
PMID: 17122017
A range of species of Chlamydiales have previously been detected in a variety of Australian marsupials, including koalas and western barred bandicoots. Thirty-seven ocular, urogenital, or nasal swabs were obtained...
6.
Kumar S, Kohlhoff S, Gelling M, Roblin P, Kutlin A, Kahane S, et al.
Pediatr Infect Dis J
. 2005 Nov;
24(11):989-92.
PMID: 16282935
Background: Simkania negevensis is a Chlamydia-like intracellular organism that is prevalent in populations from a wide range of geographic areas. The role of the organism in respiratory disease in the...
7.
Kutlin A, Kohlhoff S, Roblin P, Hammerschlag M, Riska P
Antimicrob Agents Chemother
. 2005 Feb;
49(3):903-7.
PMID: 15728882
Although rifamycins have excellent activity against Chlamydophila pneumoniae and Chlamydia trachomatis in vitro, concerns about the possible development of resistance during therapy have discouraged their use for treatment of chlamydial...
8.
Riska P, Kutlin A, Ajiboye P, Cua A, Roblin P, Hammerschlag M
Antimicrob Agents Chemother
. 2004 Aug;
48(9):3586-90.
PMID: 15328134
Three clinical Chlamydia pneumoniae isolates for which the MIC of azithromycin increased after treatment were investigated for genetic evidence of macrolide resistance. Attempts to induce antibiotic resistance in vitro were...
9.
Hogan R, Mathews S, Kutlin A, Hammerschlag M, Timms P
Microb Pathog
. 2003 Mar;
34(1):11-6.
PMID: 12620380
Chlamydia pneumoniae is associated with several chronic human diseases, including chronic obstructive pulmonary disease and atherosclerotic cardiovascular disease. During chronic disease, organisms are believed to exist in a persistent phase...
10.
Roblin P, Reznik T, Kutlin A, Hammerschlag M
Antimicrob Agents Chemother
. 2003 Feb;
47(3):1135-6.
PMID: 12604555
ABI-1648 (rifalazil) is a semisynthetic rifamycin with potent bactericidal activity against intracellular respiratory bacteria, including Mycobacterium tuberculosis, and a long half-life (approximately 60 h) and thus can be administered once...